Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05001516
Title Study of Turning Point Therapeutics LM-302 in Patients With Advance Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Turning Point Therapeutics, Inc.
Indications

Advanced Solid Tumor

ovarian mucinous adenocarcinoma

colorectal carcinoma

pancreatic carcinoma

esophagus adenocarcinoma

gastric adenocarcinoma

biliary tract cancer

gastroesophageal junction adenocarcinoma

ovarian carcinoma

Therapies

LM-302

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST